Peter Fernandes - 10 Feb 2023 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
CHIEF EXECUTIVE OFFICER
Signature
/s/ Peter Fernandes
Issuer symbol
BLPH
Transactions as of
10 Feb 2023
Transactions value $
$152,000
Form type
4
Filing time
14 Feb 2023, 15:46:36 UTC
Previous filing
13 Dec 2022
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Stock Options (right to buy) Award $152,000 +100,000 $1.52 100,000 10 Feb 2023 Common Stock 100,000 $1.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.